For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.
Dr. Douglas B. Johnson
Advertisement
Dr. Douglas B. Johnson is a physician-scientist and professor of medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center, where he leads the melanoma clinical research program, located in Nashville, Tennessee.
Articles by Dr. Douglas B. Johnson
Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment.
Advertisement
Latest Updated Articles
Expert Shares Key Insights During Melanoma Awareness MonthPublished: May 9th 2025 | Updated:
- Immune Therapy Expands Melanoma Treatment to More Patients
Published: May 6th 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Body Image and Sexual Health Challenges After Breast Cancer
2
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
3
Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery
4
What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?
5
